TNF and SAPHO syndrome: Many case reports and a case series have shown that TNF-α antagonists can significantly improve skin lesions and bone pain symptoms in patients with SAPHO syndrome.[14,15] However, some studies[16] have shown that, in patients with rheumatic immune disease treated with TNF-α antagonists, a small number of patients have new skin lesions or aggravated original skin lesions during treatment.